Obviously, we are working in an extremely strained environment where all countries are seeking access to vaccines as one way through the pandemic. The environment is incredibly competitive and supply chains are ramping up, so we are watching supply chains on a daily basis to make sure that we are able to get product, vaccines, into the country as soon as possible.
One way that we've managed the unpredictability of supply chains in a competitive environment is by working with our suppliers, Pfizer, for example, to move the supply chain from Europe to the United States. As of the beginning of May, we have started to bring Pfizer doses in from Kalamazoo, Michigan, as opposed to Europe. We are in discussions with Moderna at the current time to ensure that we can make a similar shift and move the supply chain from Europe to the United States so that we can increase the stability, especially in transportation, of doses of vaccine coming into Canada.